Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinm-piperaquine in patients with Plasmodium falciparum malaria in Thailand

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 1052-1061

  Tarning, J ^a,c   Ashley, E A ^b,c,d,e   Lindegardh, N ^c,d   Stepniewska, K ^c,d   Phaiphun, L ^b   Day, N P J ^c,d   McGready, R ^b,c,d   Ashton, M ^a   Nosten, F ^b,c,d   White, N J ^c,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e EPICENTRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; PIPERAQUINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CHILD; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISCRIMINATION; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THAILAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; QUINOLINES; THAILAND; TREATMENT OUTCOME;

EID: 40549113955     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00955-07     Document Type: Article

References (33)

1. Ashley, E. A., S. Krudsood, L. Phaiphun, S. Srivilairit, R. McGready, W. Leowattana, R. Hutagalung, P. Wilairatana, A. Brockman, S. Looareesuwan, F. Nosten, and N. J. White. 2004. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J. Infect. Dis. 190:1773-1782.
2. Ashley, E. A., R. McGready, R. Hutagalung, L. Phaiphun, T. Slight, S. Proux, K. L. Thwai, M. Barends, S. Looareesuwan, N. J. White, and F. Nosten. 2005. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin. Infect. Dis. 41:425-432.
3. Beal, S. L. 2001. Ways to fit a PK model with some data below the quantification limit. J. Pharmacokinet. Pharmacodyn. 28:481-504.
4. Beal, S. L., and L. B. Sheiner. 1982. Estimating population kinetics. Crit. Rev. Biomed. Eng. 8:195-222.
5. Beal, S. L., A. J. Boeckman, and L. B. Sheiner. 1992. NONMEM users guides. NONMEM Project Group, University of California at San Fransisco, San Fransisco, CA.
6. Brockman, A., R. E. Paul, T. J. Anderson, I. Hackford, L. Phaiphun, S. Looareesuwan, F. Nosten, and K. P. Day. 1999. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am. J. Trop. Med. Hyg. 60:14-21.
7. Crevoisier, C., J. Handschin, J. Barre, D. Roumenov, and C. Kleinbloesem. 1997. Food increases the bioavailability of mefloquine. Eur. J. Clin. Pharmacol. 53:135-139.
8. Denis, M. B., T. M. Davis, S. Hewitt, S. Incardona, K. Nimol, T. Fandeur, Y. Poravuth, C. Lim, and D. Socheat. 2002. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35:1469-1476.
9. Feldman, C., and G. Sarosi. 2005. Tropical and parasitic infections in the intensive care unit, vol. 9. Springer US, Boston, MA.
10. Ginsberg, G., D. Hattis, B. Sonawane, A. Russ, P. Banati, M. Kozlak, S. Smolenski, and R. Goble. 2002. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci. 66:185-200.
11. Hasugian, A. R., H. L. Purba, E. Kenangalem, R. M. Wuwung, E. P. Ebsworth, R. Maristela, P. M. Penttinen, F. Laihad, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin. Infect. Dis. 44:1067-1074.
12. Holford, N. 2005. A degenerative predictive check, abstr. 738, p. 14. Abstr. 14th Annu. Meet. Pop. Appr. Group Eur., Pop. Appr. Group Eur., Pamplona, Spain. www.page-meeting.org/?abstract=738.
13. Hung, T. Y., T. M. Davis, K. F. Ilett, H. Karunajeewa, S. Hewitt, M. B. Denis, C. Lim, and D. Socheat. 2004. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br. J. Clin. Pharmacol. 57:253-262.
14. Johnson, T. N., A. Rostami-Hodjegan, and G. T. Tucker. 2006. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin. Pharmacokinet. 45:931-956.
15. Jonsson, E. N., and M. O. Karlsson. 1999. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput. Methods Prog. Biomed. 58:51-64.
16. Karunajeewa, H., C. Lim, T. Y. Hung, K. F. Ilett, M. B. Denis, D. Socheat, and T. M. Davis. 2004. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br. J. Clin. Pharmacol. 57:93-99.
17. Lindegårdh, N., N. J. White, and N. P. Day. 2005. High throughput assay for the determination of piperaquine in plasma. J. Pharm. Biomed Anal. 39: 601-605.
18. Luxemburger, C., K. L. Thwai, N. J. White, H. K. Webster, D. E. Kyle, L. Maelankirri, T. Chongsuphajaisiddhi, and F. Nosten. 1996. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 90:105-111.
19. Milton, K. A., G. Edwards, S. A. Ward, M. L. Orme, and A. M. Breckenridge. 1989. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br. J. Clin. Pharmacol. 28:71-77.
20. Price, R. N., A. R. Hasugian, A. Ratcliff, H. Siswantoro, H. L. Purba, E. Kenangalem, N. Lindegardh, P. Penttinen, F. Laihad, E. P. Ebsworth, N. M. Anstey, and E. Tjitra. 2007. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Antimicrob. Agents Chemother. 51:4090-4097.
21. Ratcliff, A., H. Siswantoro, E. Kenangalem, R. Maristela, R. M. Wuwung, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369:757-765.
22. Rolan, P. E., A. J. Mercer, B. C. Weatherley, T. Holdich, H. Meire, R. W. Peck, G. Ridout, and J. Posner. 1994. Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br. J. Clin. Pharmacol. 37:13-20.
23. Roshammar, D., T. N. Hai, S. Friberg Hietala, N. Van Huong, and M. Ashton. 2006. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur. J. Clin. Pharmacol.
24. Sim, I. K., T. M. Davis, and K. F. Ilett. 2005. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob. Agents Chemother. 49:2407-2411.
25. Tangpukdee, N., S. Krudsood, W. Thanachartwet, K. Chalermrut, C. Pengruksa, S. Srivilairit, U. Silachamroon, P. Wilairatana, S. Phongtananant, S. Kano, and S. Looareesuwan. 2005. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J. Trop. Med. Public Health 36:1085-1091.
26. Taming, J., Y. Bergqvist, N. P. Day, J. Bergquist, B. Arvidsson, N. J. White, M. Ashton, and N. Lindegardh. 2006. Characterization of human urinary metabolites of the antimalarial piperaquine. Drug Metab. Dispos. 34:2011-2019.
27. Tarning, J., N. Lindegardh, A. Annerberg, T. Singtoroj, N. P. Day, M. Ashton, and N. J. White. 2005. Pitfalls in estimating piperaquine elimination. Antimicrob. Agents Chemother. 49:5127-5128.
28. Taming, J., T. Singtoroj, A. Annerberg, M. Ashton, Y. Bergqvist, N. J. White, N. P. Day, and N. Lindegardh. 2006. Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine. J. Pharm. Biomed. Anal. 41:213-218.
29. Tran, T. H., C. Dolecek, P. M. Pham, T. D. Nguyen, T. T. Nguyen, H. T. Le, T. H. Dong, T. T. Tran, K. Stepniewska, N. J. White, and J. Farrar. 2004. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363:18-22.
30. Wählby, U., M. R. Bouw, E. N. Jonsson, and M. O. Karlsson. 2002. Assessment of type I error rates for the statistical sub-model in NONMEM. J. Pharmacokinet. Pharmacodyn. 29:251-269.
31. Wählby, U., E. N. Jonsson, and M. O. Karlsson. 2001. Assessment of actual significance levels for covariate effects in NONMEM. J. Pharmacokinet. Pharmacodyn. 28:231-252.
32. White, N. J. 1999. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41:301-308.
33. Wilkins, J. J. 2005. NONMEMory: a run management tool for NONMEM. Comput. Methods Prog. Biomed. 78:259-267.